Methods & Compositions for the Activation of Gamma-delta T-cells
Country:
US
Docket No:
436313-000339
Publication Number:
10,472,649
Patent Expiry:
01/13/2037
Claims Scope:
Patent issued November 12, 2019.
Sequence Agnostic – Composition only
Composition of an immunotherapy system with a therapeutic vector encoding at least one shRNA or miRNA that inhibits FDPS.
No limitation to activating GD T cells or infecting cancer cells.
